

The Science Council leads ERS’s science-related activities. Science is a key pillar of the Society.
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
AstraZeneca | Ad board, consultancy | B |
GSK | Ad board, consultancy, steering committee | C |
Chiesi | Ad board, consultancy, presentation | C |
Biosency | consultancy | A |
Menarini | presentation | B |
Sanofi | ad board | C |
NOvartis | Ad board | B |
Zambon | presentation | B |
Teva | ad board | A |
Pfizer | ad board | A |
MSD | presentation | A |
ALK | presentation | B |
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
Chiesi | CPLF | A |
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
GSK | research | D |
Pfizer | research | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Company | Area | Product | Amount of funds received* |
---|---|---|---|
CSL Behring | Autoimmune and inflammatory | NA | A |
Areteia Therapeutics | Asthma | Dexpramipexole Phase III program | A |
Astra Zeneca | EGPA & Asthma | FLAP inhibitor Phase II program, Asthma advisory and EGPA | C |
Chiesi | Asthma | NA | B |
GSK | Asthma | NA | B |
None
None
Company | Approximate value* |
---|---|
Eupnoos Limited (co-founder, % company equity stake) | C |
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Ioannis Vogiatzis
Christian Karagiannidis
Irene H. Heijink
Winfried Randerath
Omar S. Usmani
Charlotte Suppli Ulrik
Marielle W.H. Pijnenburg
Federica Meloni
Daniel Langer
Eva Polverino
Torsten Gerriet Blum
Katerina Antoniou
Anton Vonk Noordegraaf
Walter de Wever
Sejal Saglani, UK (Chair)
Argyrios Tzouvelekis, Greece
Nicolas Reynoird, France
Mirela Ciontu, Romania
Lorenzo Guglielmetti, France
Niki Ubags, Switzerland
Cristina Ardura-Garcia, Switzerland
Aleksandra Szczepankiewicz, Poland
Georgia Hardavella, Greece
Richard Lee, UK
Mathieu Marillier, France
Henrik Hansen, Denmark
Suzanne Cloonan, Ireland
Savai Pullamsetti Soni, Germany
Christoph Fisser, Germany
Susanne Vijverberg, Netherlands
Afroditi Boutou, Greece
Marielle W.H. Pijnenburg, Netherlands
Richard Staats, Portugal
Orianne Dumas, France
Joana Pepke-Zaba, UK
Franz de Jongh, Netherlands
Salman Siddiqui, UK (Chair)
Andre Nyberg, Sweden
Andrew Bush, UK
Amanda Dandanell, Juul Denmark
Apostolos Bossios, Sweden
Begüm Ergan, Turkey
Christoph Lange, Germany
Delia Goletti, Italy
Joanna Chorostowska, Poland
Joanna Pepke-Zaba, UK
Jakob Usemann, Switzerland
Marieke Duiverman, Netherlands
Raphael Heinzer, Switzerland
Simon Walsh, UK
Vivi Schlünssen, Denmark
Andrew Bush, United Kingdom (Chair)
Amanda Dandanell Juul, Denmark
Johan Verbraecken, Belgium
Salman Siddiqui, United Kingdom
Stelios Loukides, Greece
Marieke Duiverman, Netherlands
Sylvia Ulrich, Switzerland
Amanda Tufman, Germany
Angela Zacharasiewicz, Austria
Jibril Mohammed, Nigeria
Rosanne Beijers, Netherlands
Pieter Goeminne, Belgium
Judith Garcia Aymerich, Spain
Hilary Pinnock, United Kingdom
Martin Kolb, Canada
Winfried Randerath, Germany